Results 51 to 60 of about 295,984 (208)

24h group of fungal keratitis

open access: yes, 2023
  24h group of fungal keratitis     
Bowen Wang (11466184)
core   +1 more source

Development of nanodrug-based eye drops with good penetration properties and ROS responsiveness for controllable release to treat fungal keratitis

open access: yesNPG Asia Materials, 2023
Fungal keratitis is challenging to diagnose and treat and remains a significant cause of blindness worldwide. The easiest and most common method of drug delivery for patients with fungal keratitis is eye drop administration.
Panhong Niu   +5 more
doaj   +1 more source

Advanced nanotherapeutics for combating ocular infections: Rational design, antimicrobial mechanisms, and therapeutic breakthroughs

open access: yesBMEMat, EarlyView.
Nanomaterials revolutionize ocular infection treatment by enabling targeted drug delivery and enhanced antimicrobial efficacy against resistant pathogens. This review systematically explores their rational design, multimodal mechanisms, and translational potential for next‐generation anti‐infective therapies.
Yujia Liu   +7 more
wiley   +1 more source

In Vitro Efficacy of Chlorhexidine and a riboflavin/UVA Combination on Fungal Agents of Keratitis

open access: yes, 2019
Purpose: Mycotic keratitis is a global ophthalmological problem because it is difficult to diagnose and treat. The aim of the current study was to evaluate the efficiency of using antifungal agents amphotericin B (AMB), voriconazole (VRC), 0.02 ...
Kandemir, Hazal   +8 more
core   +1 more source

control group of fungal keratitis

open access: yes, 2023
 control group of fungal keratitis   
Bowen Wang (11466184)
core   +1 more source

Distinguishing fungal and bacterial keratitis on clinical signs. [PDF]

open access: yes, 2015
In many settings, laboratory support for the diagnosis of the type of microbial keratitis is not available. Experienced ophthalmologists have long maintained that it is sometimes possible to distinguish fungal from bacterial microbial keratitis on the ...
Matthew Burton   +3 more
core  

8h group of fungal keratitis

open access: yes, 2023
8h group of fungal keratitis    
Bowen Wang (11466184)
core   +1 more source

Medical interventions for fungal keratitis [PDF]

open access: yes, 2003
Fungal keratitis is common in agricultural tropical countries but relatively uncommon in developed countries. Although there are medications available, their effectiveness is unclear.The purpose of the review was to examine the effect of different antifungal drugs in the management of fungal keratitis.We searched the Cochrane Central Register of ...
N V, Florcruz, I, Peczon
openaire   +4 more sources

Chlorhexidine 0.02% or polyhexamethylene biguanide 0.02% as the main treatment for Acanthamoeba keratitis

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To report medical cure and treatment failure rates of Acanthamoeba keratitis (AK) with respect to type of treatment, disease stage and prognostic factors. Methods Electronic records were reviewed for 45 patients with PCR‐positive AK treated at the Department of Ophthalmology, Aarhus University Hospital, Denmark from 2012 to 2025 ...
Anders Ivarsen   +5 more
wiley   +1 more source

Murine model for Fusarium oxysporum invasive fusariosis reveals organ-specific structures for dissemination and long-term persistence [PDF]

open access: yes, 2014
Peer ...
Gow, Neil A. R.   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy